GlassScriptPhysician profile
Olesya Griffith
NPI 1194200733
$3,162.35
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,434 · 2022: $1,729.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $1,489.23 | 2022 | |
| Abbvie INC. | $376.14 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $260.50 | 2021 | |
| Clarus Therapeutics INC. | $160.77 | 2021 | |
| Glaxosmithkline, LLC. | $148.01 | 2021 | |
| Esperion Therapeutics, INC. | $147.45 | 2021 | |
| Lilly USA, LLC | $120.16 | 2021-2022 | |
| Pfizer INC. | $77.80 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.27 | 2021 | |
| Lundbeck LLC | $49.51 | 2021-2022 | |
| Novo Nordisk INC | $47.74 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $34.16 | 2022 | |
| Astellas Pharma US INC | $28.81 | 2021 | |
| Amgen INC. | $26.09 | 2021-2022 | |
| Upsher-Smith Laboratories LLC | $22.48 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $21.62 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.23 | 2021 | |
| Eisai INC. | $19.90 | 2021 | |
| Aytu Biopharma, INC. | $18.87 | 2021 | |
| Sanofi Pasteur INC. | $14.94 | 2021 | |
| Bausch Health US, LLC | $14.22 | 2022 | |
| Supernus Pharmaceuticals, INC. | $12.45 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olesya Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.